z-logo
Premium
The Tertiary Amine Nitrogen Atom of Piperazine Sulfonamides as a Novel Determinant of Potent and Selective β 3 ‐Adrenoceptor Agonists
Author(s) -
Perrone Maria Grazia,
Bleve Laura,
Santandrea Ernesto,
Vitale Paola,
Niso Mauro,
Scilimati Antonio
Publication year - 2009
Publication title -
chemmedchem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.200900292
Subject(s) - piperazine , piperidine , sulfonamide , chemistry , propanoic acid , amine gas treating , tertiary amine , stereochemistry , molecule , medicinal chemistry , morpholine , organic chemistry
Novel compounds were prepared in fair to good yields as human β 3 ‐adrenoceptor (β 3 ‐AR) agonists. In particular, aryloxypropanolamines 7 a – d (EC 50 =0.57–2.1 n M ) and arylethanolamines 12 a , b , e (EC 50 =6.38–19.4 n M ) were designed to explore the effects of modifications at the right‐hand side of these molecules on their activity as β 3 ‐AR agonists. Piperidine sulfonamides 15 a – c ,  e – g (EC 50 =6.1–36.2 n M ) and piperazine sulfonamide derivatives 20 – 29 (EC 50 =1.79–49.3 n M ) were examined as compounds bearing a non‐aromatic linker on the right‐ and left‐hand sides of the molecules. Some piperazine sulfonamides were found to be potent and selective β 3 ‐AR agonists, even if the amine nitrogen atom is tertiary and not secondary, as is the case for all β 3 ‐AR agonists reported so far. ( S )‐3‐{4‐{ N ‐{4‐{2‐[2‐Hydroxy‐3‐(4‐hydroxyphenoxy)propylamino]ethyl}phenyl}sulfamoyl}phenoxy}propanoic acid ( 7 d ; EC 50 =0.57 n M ), ( R )‐ N ‐{4‐[2‐(2‐hydroxy‐2‐phenylethylamino)ethyl]phenyl}‐4‐(3‐octylureido)benzenesulfonamide ( 12 e ; EC 50 =6.38 n M ), ( R )‐2‐[1‐(4‐methoxyphenylsulfonyl)piperidin‐4‐ylamino]‐1‐phenylethanol ( 15 f ; EC 50 =6.1 n M ), and ( S )‐4‐{2‐hydroxy‐3‐[4‐(4‐methoxyphenylsulfonyl)piperazin‐1‐yl]propoxy}phenol ( 25 ; EC 50 =1.79 n M ) were found to be the most potent β 3 ‐AR agonists of the aryloxypropanolamine, arylethanolamine, piperidine sulfonamide, and piperazine sulfonamide classes, respectively. The two most potent compounds were identified as possible candidates for further development of β 3 ‐AR agonists useful in the treatment of β 3 ‐AR‐mediated pathological conditions.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom